Shouping Xu

157 Baojian Road
Harbin, 150086, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Electric field regulated wettability switching of three-dimensional nickel foam for on-demand separation of multiple emulsions and flux self-recovery.

Electric field regulated wettability switching of three-dimensional nickel foam for on-demand separation of multiple emulsions and flux self-recovery.

Journal: Journal of hazardous materials

Published: May 10, 2026

Clinicopathological Characteristics, Prognosis, and Survival of HER2-Low Breast Cancer Patients Based on a Retrospective Cohort Study of 14,642 Patients.

Clinicopathological Characteristics, Prognosis, and Survival of HER2-Low Breast Cancer Patients Based on a Retrospective Cohort Study of 14,642 Patients.

Journal: Cancers

Published: March 16, 2026

Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer: final analysis of the randomized RATIONALE-315 trial.

Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer: final analysis of the randomized RATIONALE-315 trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 29, 2025

Integrated Proteogenomic Characterization Identifies Breast Cancer Immune Subgroups and Subtype-Specific Therapeutic Strategies.

Integrated Proteogenomic Characterization Identifies Breast Cancer Immune Subgroups and Subtype-Specific Therapeutic Strategies.

Journal: Research (Washington, D.C.)

Published: July 23, 2025

Proteogenomic Characterization Reveals Subtype-Specific Therapeutic Potential for HER2-Low Breast Cancer.

Proteogenomic Characterization Reveals Subtype-Specific Therapeutic Potential for HER2-Low Breast Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 17, 2025

mRNA nanomedicine reprograms the cell cycle to increase the effectiveness of targeted therapy for HER2-low breast cancers.

mRNA nanomedicine reprograms the cell cycle to increase the effectiveness of targeted therapy for HER2-low breast cancers.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: July 02, 2025

Tumour-associated high endothelial venules drive portal-specific immune evasion in lymph nodes via ALOX12.

Tumour-associated high endothelial venules drive portal-specific immune evasion in lymph nodes via ALOX12.

Journal: Nature communications

Published: April 16, 2025

Integrating ctDNA Dynamics and Sequential Organoid Drug Screening Enhances Breast Cancer Treatment Efficacy.

Integrating ctDNA Dynamics and Sequential Organoid Drug Screening Enhances Breast Cancer Treatment Efficacy.

Journal: Cancer research

Published: February 10, 2025

Identification of Novel Anoikis-Related Gene Signatures to Predict the Prognosis, Immune Microenvironment, and Drug Sensitivity of Breast Cancer Patients.

Identification of Novel Anoikis-Related Gene Signatures to Predict the Prognosis, Immune Microenvironment, and Drug Sensitivity of Breast Cancer Patients.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: September 28, 2024

Identifying T cell antigen at the atomic level with graph convolutional network.

Identifying T cell antigen at the atomic level with graph convolutional network.

Journal: Nature communications

Published: September 27, 2024

NAT10/ac4C/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction.

NAT10/ac4C/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 22, 2024

Higher baseline platelet and preoperative platelets to lymphocytes ratio was associated with a higher incidence of axillary node pathologic complete response after neoadjuvant chemotherapy in HER2-low breast cancer: a retrospective cohort study.

Higher baseline platelet and preoperative platelets to lymphocytes ratio was associated with a higher incidence of axillary node pathologic complete response after neoadjuvant chemotherapy in HER2-low breast cancer: a retrospective cohort study.

Journal: Frontiers in oncology

Published: May 24, 2024

Showing 1-12 of 80

Last Updated: 09/26/2026